Precision Oncology

Precision oncology is a new approach to cancer treatment, which utilizes the molecular profiling of each tumor to develop and tailor treatment strategies to each patient. The use of these biomarkers from tumors will help to predict those who will respond to specific treatments. Here is the latest research on precision oncology.

July 4, 2020

New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Ancuta JurjCornelia Braicu
July 1, 2020
Open Access

NCI-Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center

Journal of Clinical Medicine
Daniel J KimTanya Dorff
July 4, 2020

Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Ren-Chin WuChyong-Huey Lai
July 1, 2020
Review

Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?

Acta Pharmacologica Sinica
Chen-Xi ZhaoHong Zhu
July 1, 2020
Open Access

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study

JNCI Cancer Spectrum
Stefan KlekPauline Funchain
July 1, 2020

Landscape of RAS Variations in 17,993 Pan-cancer Patients Identified by Next-generation Sequencing

Pathology Oncology Research : POR
Shaoqiang ZhouHao Wu
July 1, 2020
Review

Sequencing Therapies for Metastatic Renal Cell Carcinoma

The Urologic Clinics of North America
Nazli DizmanSumanta K Pal
July 2, 2020

The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction

Cellular and Molecular Life Sciences : CMLS
Silvia SantopoloM Gabriella Santoro
June 29, 2020
Preprint
Open Access

Identification of a novel missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

BioRxiv : the Preprint Server for Biology
Ryan S DhindsaS. Petrovski
July 3, 2020
Review

Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors

American Journal of Clinical Dermatology
Vincent SibaudLoic Ysebaert
July 1, 2020
Open Access

The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients

International Journal of Molecular Sciences
Nicholas EastleyNicola J Royle
July 1, 2020
Review

Cytoreductive Nephrectomy in the Era of Tyrosine Kinase and Immuno-Oncology Checkpoint Inhibitors

The Urologic Clinics of North America
Michael J BilesMohamad E Allaf
July 2, 2020
Review
Open Access

Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer

In Vivo
Nikolaos GarmpisAfroditi Nonni
July 2, 2020
Case Report

Comprehensive treatment of rare multiple endocrine neoplasia type 1: A case report

World Journal of Clinical Cases
Chen-Hui MaWan-Xing Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved
/feed-previews/precision-oncology/18be929d-593b-4a86-83de-155b6e8082c9